LINC02593: A Drug Target / Disease Biomarker (G100130417)

Target Name: LINC02593

NCBI ID: G100130417

LINC02593

Other Name(s): Long intergenic non-protein coding RNA 2593, transcript variant 1 | long intergenic non-protein coding RNA 2593

LINC02593: A Drug Target / Disease Biomarker

LINC02593 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is located in chromosome 6q24 and has been shown to be involved in a variety of physiological processes, including cell growth, differentiation, and survival.

Recent studies have suggested that LINC02593 may be a good candidate for drug development due to its unique biology and favorable expression profile in various tissues. LINC02593 has been shown to be highly expressed in a variety of tissues, including brain, heart, liver, and muscle. It has also been shown to be expressed in various cell types, including cancer cells, and has been shown to play a role in the development and progression of various diseases, including cancer.

In addition to its potential as a drug target, LINC02593 has also been shown to be a potential biomarker for a variety of diseases. For example, studies have shown that LINC02593 is downregulated in various diseases, including cancer, and that increasing levels of LINC02593 may be associated with disease progression. Additionally, LINC02593 has been shown to be associated with various biomarkers, including the expression of other genes involved in cancer progression, such as the T cells present in the immune system.

Despite the potential for LINC02593 as a drug target and biomarker, further research is needed to fully understand its role in disease. studies are needed to determine the mechanism of action of LINC02593 and to determine its potential efficacy as a drug. Additionally, research is needed to determine the safety and efficacy of LINC02593 as a drug in animal models of disease.

In conclusion, LINC02593 is a promising candidate for drug development due to its unique biology and favorable expression profile in various tissues. Further research is needed to fully understand its role in disease and to determine its potential as a drug and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2593

The "LINC02593 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02593 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets